OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Antimicrobial resistance (AMR) is increasingly being recognised as a complex global health threat requiring concerted efforts from different sectors of society to address its root causes. Community Engagement, which is seen as central to addressing AMR, needs to be combined with stakeholder engagement to scale findings to policies and practices. Responsive Dialogues on Drug Resistant Infections is a model that provides guidance for doing just that: bringing different stakeholders together to discuss, debate and respond to evidence and information about AMR, and generating concrete practical steps to addressing the issue at community and policy levels.
In ths webinar exploring Community Engagement for AMR, speakers will share findings from pilot projects run by Malawi-Liverpool-Wellcome Trust (MLW) in Malawi and Mahidol Oxford Tropical Medicine Research Unit (MORU) in Thailand. Join this event to learn about the approaches used, key findings about community’s understanding of, engagement with, and possible solutions to AMR, and discuss pathways to scale.
Chair: Dr Mirfin Mpundu, Director, ReAct Africa and Partnerships and Stakeholder Engagement Lead Africa, ICARS
Speakers:
Dr Bhensri Naemiratch, Medical Anthropologist, Mahidol Oxford Tropical Medicine Research Unit, Thailand
Dr Anne Osterrieder, Public Engagement Evaluation and Learning Lead, Mahidol Oxford Tropical Medicine Research Unit, Thailand
John Mankhomwa, Medical Anthropologist, Malawi Liverpool Wellcome Trust Clinical Research Unit, Malawi
Mackwellings Phiri, Social Scientist, Malawi Liverpool Wellcome Trust Clinical Research Unit, Malawi